NeurologyLive® Staff

home / authors / neurologylive-staff

Articles

This Week on NeurologyLive® — May 8, 2023

This Week on NeurologyLive® — May 8, 2023

NeurologyLive® Staff
May 8th 2023

Here's some of what is coming soon to NeurologyLive® this week.

Zavegepant Effective Regardless of Aura Status, FDA Approves Extended-Release Sodium Oxybate, Mediterranean Diet Adherence Improves MS Cognition

Zavegepant Effective Regardless of Aura Status, FDA Approves Extended-Release Sodium Oxybate, Mediterranean Diet Adherence Improves MS Cognition

NeurologyLive® Staff
May 6th 2023

Neurology News Network for the week ending May 6, 2023. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — May 5, 2023

NeurologyLive® Friday 5 — May 5, 2023

NeurologyLive® Staff
May 5th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 5, 2023.

This Week on NeurologyLive® — May 1, 2023

This Week on NeurologyLive® — May 1, 2023

NeurologyLive® Staff
May 1st 2023

Here's some of what is coming soon to NeurologyLive® this week.

Atogepant's Impact on Chronic Migraine, LD/CD Intra-Oral Pump Improves ON Time, Ravulizumab Effective in NMOSD Subgroups

Atogepant's Impact on Chronic Migraine, LD/CD Intra-Oral Pump Improves ON Time, Ravulizumab Effective in NMOSD Subgroups

NeurologyLive® Staff
April 30th 2023

Neurology News Network for the week ending April 30, 2023. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — April 28, 2023

NeurologyLive® Friday 5 — April 28, 2023

NeurologyLive® Staff
April 28th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 28, 2023.

This Week on NeurologyLive® — April 24, 2023

This Week on NeurologyLive® — April 24, 2023

NeurologyLive® Staff
April 24th 2023

Here's some of what is coming soon to NeurologyLive® this week.

DEA Rules Fenfluramine No Longer Controlled Substance, Positive FDA ADComm Meeting of Brexpiprazole, Antiamyloid Drugs Accelerate Brain Atrophy

DEA Rules Fenfluramine No Longer Controlled Substance, Positive FDA ADComm Meeting of Brexpiprazole, Antiamyloid Drugs Accelerate Brain Atrophy

NeurologyLive® Staff
April 22nd 2023

Neurology News Network for the week ending April 22, 2023. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — April 21, 2023

NeurologyLive® Friday 5 — April 21, 2023

NeurologyLive® Staff
April 21st 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 21, 2023.

This Week on NeurologyLive® — April 17, 2023

This Week on NeurologyLive® — April 17, 2023

NeurologyLive® Staff
April 17th 2023

Here's some of what is coming soon to NeurologyLive® this week.

EASEE Device Reduces Seizures in DRE, Narcolepsy Incidence Increased During H1N1 Pandemic, Trial of GTX-104 Moving Forward

EASEE Device Reduces Seizures in DRE, Narcolepsy Incidence Increased During H1N1 Pandemic, Trial of GTX-104 Moving Forward

NeurologyLive® Staff
April 15th 2023

Neurology News Network for the week ending April 15, 2023. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — April 14, 2023

NeurologyLive® Friday 5 — April 14, 2023

NeurologyLive® Staff
April 14th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 14, 2023.

This Week on NeurologyLive® — April 10, 2023

This Week on NeurologyLive® — April 10, 2023

NeurologyLive® Staff
April 10th 2023

Here's some of what is coming soon to NeurologyLive® this week.

Remternetug Significantly Reduces Amyloid Plaque, Phase 3 INTUNE Study Accelerated, Pitolisant Approved for Pediatric Narcolepsy by EMA

Remternetug Significantly Reduces Amyloid Plaque, Phase 3 INTUNE Study Accelerated, Pitolisant Approved for Pediatric Narcolepsy by EMA

NeurologyLive® Staff
April 8th 2023

Neurology News Network for the week ending April 8, 2023. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — April 7, 2023

NeurologyLive® Friday 5 — April 7, 2023

NeurologyLive® Staff
April 7th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 7, 2023.

This Week on NeurologyLive® — April 3, 2023

This Week on NeurologyLive® — April 3, 2023

NeurologyLive® Staff
April 3rd 2023

Here's some of what is coming soon to NeurologyLive® this week.

Lecanemab Adds Quality-Adjusted Life Years, FDA to Hold AdComm Meeting Over NurOwn, SYMBYX Neuro Improves PD Symptoms

Lecanemab Adds Quality-Adjusted Life Years, FDA to Hold AdComm Meeting Over NurOwn, SYMBYX Neuro Improves PD Symptoms

NeurologyLive® Staff
April 1st 2023

Neurology News Network for the week ending April 1, 2023. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — March 31, 2023

NeurologyLive® Friday 5 — March 31, 2023

NeurologyLive® Staff
March 31st 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 31, 2023.

This Week on NeurologyLive® — March 27, 2023

This Week on NeurologyLive® — March 27, 2023

NeurologyLive® Staff
March 27th 2023

Here's some of what is coming soon to NeurologyLive® this week.

NeurologyLive® Friday 5 — March 24, 2023

NeurologyLive® Friday 5 — March 24, 2023

NeurologyLive® Staff
March 24th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 24, 2023.

This Week on NeurologyLive® — March 20, 2023

This Week on NeurologyLive® — March 20, 2023

NeurologyLive® Staff
March 20th 2023

Here's some of what is coming soon to NeurologyLive® this week.

Cognitive and Functional Differences in Parkinson, FDA Lifts Hold on IkT-148009, Solanezumab Shows No Impact on Cognitive Decline

Cognitive and Functional Differences in Parkinson, FDA Lifts Hold on IkT-148009, Solanezumab Shows No Impact on Cognitive Decline

NeurologyLive® Staff
March 18th 2023

Neurology News Network for the week ending March 18, 2023. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — March 17, 2023

NeurologyLive® Friday 5 — March 17, 2023

NeurologyLive® Staff
March 17th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 17, 2023.

This Week on NeurologyLive® — March 13, 2023

This Week on NeurologyLive® — March 13, 2023

NeurologyLive® Staff
March 13th 2023

Here's some of what is coming soon to NeurologyLive® this week.

Efgartigimod Improves HR-Related Quality of Life, Traditional Approval for Lecanemab Pending, Satrlizumab Benefits NMOSD After Switching

Efgartigimod Improves HR-Related Quality of Life, Traditional Approval for Lecanemab Pending, Satrlizumab Benefits NMOSD After Switching

NeurologyLive® Staff
March 11th 2023

Neurology News Network for the week ending March 11, 2023. [WATCH TIME: 3 minutes]

NeurologyLive® Friday 5 — March 10, 2023

NeurologyLive® Friday 5 — March 10, 2023

NeurologyLive® Staff
March 10th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 10, 2023.

This Week on NeurologyLive® — March 6, 2023

This Week on NeurologyLive® — March 6, 2023

NeurologyLive® Staff
March 6th 2023

Here's some of what is coming soon to NeurologyLive® this week.

Gene Therapy ST-920 Shows Benefit in Fabry, Intermittent Calorie Restriction in Multiple Sclerosis, High Economic Burden Identified in NMOSD

Gene Therapy ST-920 Shows Benefit in Fabry, Intermittent Calorie Restriction in Multiple Sclerosis, High Economic Burden Identified in NMOSD

NeurologyLive® Staff
March 4th 2023

Neurology News Network for the week ending March 4, 2023. [WATCH TIME: 3 minutes]

NeurologyLive® Friday 5 — March 3, 2023

NeurologyLive® Friday 5 — March 3, 2023

NeurologyLive® Staff
March 3rd 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 3, 2023.

This Week on NeurologyLive® — February 27, 2023

This Week on NeurologyLive® — February 27, 2023

NeurologyLive® Staff
February 27th 2023

Here's some of what is coming soon to NeurologyLive® this week.

<1
...
101112131415161718
...
37>

Latest Updated Articles

Anna Burke, MD (Credit: Barrow Neurological Institute)
Published: July 28th 2025 | Updated: July 30th 2025
Indirect Comparison Study Hints at Lower ARIA and ICH-Related Mortality Risk in Lecanemab Over Donanemab
Jannis Müller, MD, MSc (Credit: LinkedIn)
Published: May 14th 2025 | Updated: May 16th 2025
Observed Differences in PIRA Definition Call for More Standardized Agreement on Term
Giulia Fadda, MD (Credit: Ottawa Hospital Research Institute)
Published: May 12th 2025 | Updated: May 13th 2025
Serum Neurofilament Light Chain Limited in Predicting MOGAD Attacks but Correlates With Attack Severity
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
Published: March 27th 2025 | Updated: March 28th 2025
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
Published: March 4th 2025 | Updated: March 19th 2025
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Published: January 30th 2025 | Updated: February 21st 2025
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
© 2025 MJH Life Sciences

All rights reserved.